NEWS IN BRIEF: Easier Dosing

NEWS IN BRIEF: Easier Dosing

AIDS Treatment Update, Issue 65, May 1998

Boehringer-Ingelheim, manufacturer of nevirapine, is now investigating whether nevirapine can be taken once a day. Nevirapine levels decline very slowly in the blood, and some doctors in the UK are already prescribing nevirapine for once daily use. A study conducted in Germany found that nevirapine, 3TC and ddI, all taken once daily, was highly effective in suppressing viral load below the limit of detection.

Pharmacia & Upjohn, manufacturers of the NNRTI delavirdine, say that they have recent data suggesting that delavirdine may be suitable for twice daily dosing. The current recommended schedule is three times daily.

9800501
ATU6505

Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1998 - AIDS Treatment Update. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. NAM Publications 16a Clapham Common Southside, London, England SW4 7AB; TEL: 01-71-627-3200 (from outside the UK: +44-171-627-3200); FAX: 01-71-627-3101 (from outside the UK: +44=171-627-3101) info@nam.org.uk http://www.nam.org.uk

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1998. AEGIS.